Aquestive Therapeutics Inc. (AQST) Misses Q4 EPS by 13c

Aquestive Therapeutics Inc. (NASDAQ: AQST) reported Q4 EPS of ($0.26), $0.13 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $13 million versus the consensus estimate of $13.34 million.

For earnings history and earnings-related data on Aquestive Therapeutics Inc. (AQST) click here.

You May Also Be Interested In

• EQT And KKKR Said Among Firms Considering Bids For Qiagen - Bloomberg
• Wells Fargo Advances Affordable Housing and Workforce Development in Wyoming With $1 Million to Wyoming Housing Network
• Gogoro Inc (GGR) Reports Q2 Loss of $0.24, Offers FY26 Revenue Guidance